- ACT@Scale program aims to include more than 75,000
patients in five European regions by 2019
- Large-scale data analysis aims to deliver EU-wide
evidence-based recommendations for networked coordinated care and
telehealth deployment
- New initiative builds on successful ACT program and adds
large scale economic analysis
AMSTERDAM, May 17, 2016 /PRNewswire/ -- Royal Philips
(NYSE: PHG; AEX: PHIA) and a consortium of leading European
healthcare regions, companies, universities and hospitals* today
announced the start of the first large scale care coordination and
telehealth program in the European Union to support tens of
thousands of people living with chronic conditions. The three-year
ACT@Scale program will collect and analyze the health outcome and
economic impact data for large populations of chronic patients and
elderly people to develop, test and consolidate 'best practice'
care coordination and telehealth programs that can be replicable
and successfully rolled out across the European Union. The program
aims to reach more than 75,000 patients in the United Kingdom, the
Netherlands, Spain and
Denmark by 2019.
Photo - http://photos.prnewswire.com/prnh/20160516/367870
Logo - http://photos.prnewswire.com/prnh/20140122/NE50581LOGO
"Today, 70 percent of Europe's
healthcare budget is spent on patients living with chronic
conditions, largely a result of Europe's aging population and rapidly changing
care needs," said Jeroen Tas, CEO Connected Care and Health
Informatics, Philips. "Philips is committed to helping care
providers and governments implement innovative, connected care
delivery models that help improve patient self-management and care
collaboration. The ACT@Scale program will provide the evidence
needed to successfully deliver a seamless patient experience with
better outcomes at lower cost."
The five participating healthcare regions are all in the process
of rolling out innovative care coordination and telehealth
services. Within the ACT@Scale program, they will share an agreed
and standardized data set including program outcomes such as the
number of patients included, (re)hospitalizations, duration of
hospitalizations and mortality rates. They will also assess
economic impact factors such as cost per patient and the impact on
hospitals income models. This data is to support the development of
new and sustainable business models. Next to this patient
satisfaction scores are measured and the degree to which connected
technology empowers people and affects health outcomes.
The regions involved comprise Catalonia (Spain), which has developed programs to
support nursing homes, reduce hospital re-admissions, manage
complex cases and promote physical activity; Southern Denmark (Denmark), which is rolling out a
telehealth program to deliver psychiatric treatment;
Northern Ireland (UK),
which has remote telemonitoring programs to support COPD and
diabetes patients, and manage maternal obesity; Northern Netherlands (The Netherlands), with programs to provide
specialist support for COPD, asthma and heart failure patients, and
connect healthcare and community services for chronic disease
patients; and the Basque Country (Spain), which is rolling out programs to
support older people with complex health and social care needs,
plus telehealth services for chronic heart failure
patients.
"Telehealth and coordinated care services may offer the elderly
and otherwise frail individuals the ability to maintain their
independence for longer and enjoy a significantly better quality of
life, but they also involve significant changes to the healthcare
system and the recipients' ability to self-manage," said Professor
Erik Buskens, Professor of Medical
Technology Assessment at University Medical Center Groningen
(UMCG). "ACT@Scale will allow us to determine the most
cost-effective ways of implementing those changes while also
maximizing the benefits for Europe's ageing population."
First findings available end of year
The ACT@Scale
scientific consortium members comprise of University Medical Center
Groningen (The Netherlands),
Aristotle University of Thessaloniki (Greece), City University London (UK),
Universitätsklinikum Würzburg/Klinikum der Bayerischen
Julius-Maximilians-Universität (Germany), University of Hull (UK),
Kronikgune-Centre for Research Excellence in Chronicity (Basque
Country, Spain), Hospital Clinic
of Barcelona (Spain) and Philips. It is anticipated that the
first preliminary findings will be available from the end of Q4,
2016.
ACT@Scale builds on the successful ACT program, a two-and-a-half
year study (2013 – 2016) that looked into the results of European
integrated care programs. Thousands of interviews were conducted
with participating patients and care providers. These learnings on
success factors are applied to significantly grow the ACT@Scale
healthcare regions' coordination and telehealth programs. The
program is part of the European Innovation Partnership on Active
and Healthy Ageing (EIP-AHA), an initiative from the European
Commission under its Innovation Union strategy, and aims to
increase the average healthy lifespan by two years by 2020.
eHealth Week 2016
Philips, a leader in care
coordination and telehealth and a trusted partner for governments,
healthcare authorities and hospitals throughout the world, will be
showcasing its latest eHealth and coordinated care solutions at the
upcoming eHealth Week, booth N21, Hall 2 (June 8 – 10, Beurs van Berlage, Amsterdam, The Netherlands). For updates on
Philips' presence at eHealth Week, visit
www.philips.nl/ehealthweek.
For further information, please contact:
Joost Maltha
Philips Communications Healthcare Informatics Solutions and
Services
Tel. +31 6 10 55 8116
E-mail joost.maltha@philips.com
Twitter: @JoostMaltha
*About ACT @Scale
The ACT@Scale consortium members
include:
- Royal Philips
- Osakidetza-Servicio Vasco De Salud
- Asociacion Centro De Excelencia Internacional En Investigacion
Sobre Cronicidad (Kronikgune)
- Academisch Ziekenhuis Groningen * Universitair Medisch Centrum
Groningen
- Odense University Hospital
- Agencia De Qualitat I Avaluacio Sanitaries De Catalunya
- Regional Agency for Public Health and Social Well-being
- Aristotelio Panepistimio Thessalonikis * Aristotle University
of Thessaloniki
- City University London
- Universitatsklinikum Wurzburg; Klinikum Der Bayerischen
Julius-Maximilians-Universitat
- University of Hull
- Consorci Institut D'investigacions Biomèdiques August Pi I Sunyer
About Royal
Philips
Royal Philips
(NYSE: PHG, AEX: PHIA) is a leading health technology company
focused on improving people's health and enabling better outcomes
across the health continuum from healthy living and prevention, to
diagnosis, treatment and home care. Philips leverages advanced
technology and deep clinical and consumer insights to deliver
integrated solutions. The company is a leader in diagnostic
imaging, image-guided therapy, patient monitoring and health
informatics, as well as in consumer health and home care. Philips'
wholly owned subsidiary Philips Lighting is the global leader in
lighting products, systems and services. Headquartered in
the Netherlands, Philips posted
2015 sales of EUR 24.2 billion and
employs approximately 105,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.